Hospital das Clínicas da Faculdade de Medicina - HC

Logo
Inaugurado em 19 de abril de 1944, o Hospital das Clínicas da Faculdade de Medicina da USP (HC-FMUSP) é uma Autarquia de regime especial e associada à Universidade de São Paulo para fins de ensino, pesquisa, ações e serviços de saúde prestados à comunidade.

Trata-se do mais antigo sistema universitário de saúde brasileiro e ocupa posição referencial no campo do ensino, pesquisa e assistência.
O Hospital das Clínicas da FMUSP atua na área assistencial por meio de ações de promoção da saúde, prevenção das doenças, atenção médico-hospitalar no nível terciário de complexidade e reabilitação de pacientes com sequelas devidas a tratamentos de doenças.

Site oficial: http://www.hc.fm.usp.br/

Browse

Recent Submissions

  1. <i>Burnout, satisfaction and compassion fatigue: relationship with quality of care and patient safety</i>

    MUNDO DA SAUDE, v.48, n.1, 2024

  2. Has the Natural History of Primary Heart Tumors in Children Been Modified Recently?

    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, v.121, n.1, article ID e20230849, 2p, 2024

  3. Functional recovery of chronically critically ill patients in the first days after discharge from the intensive care unit: Feasibility of the 6-minute step test

    PLOS ONE, v.18, n.11, article ID e0293747, 11p, 2023

    Background Survivors of chronic critical illness often experience weakness and functional dependence to various degrees after their intensive care unit (ICU) stay. Evaluating their functional status with the traditional six-minute walk test is challenging due to space constraints or patient intol...

  4. How Can COVID-19 Influence the Evolution of Patients with Acute Coronary Syndromes?

    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, v.121, n.1, article ID e20230888, 2p, 2024

  5. Staring us in the face: resumption of CPAP therapy

    EUROPEAN RESPIRATORY JOURNAL, v.63, n.2, article ID 2302213, 3p, 2024

  6. 2023 HRS expert consensus statement on the management of arrhythmias during pregnancy

    HEART RHYTHM, v.20, n.10, 2023

    This international multidisciplinary expert consensus statement is intended to provide comprehensive guidance that can be referenced at the point of care to cardiac electrophysiologists, cardiologists, and other health care professionals, on the management of cardiac arrhythmias in pregnant patie...

  7. Myocardial Injury Progression after Radiofrequency Ablation in School-Age Children

    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, v.121, n.1, article ID e20220727, 6p, 2024

    Background: The past decades have seen the rapid development of the invasive treatment of arrhythmias by catheter ablation procedures. Despite its safety and efficacy being well-established in adults, to date there has been little data in pediatric scenarios. One of the main concerns is the possi...

  8. The Exometabolome of <i>Xylella fastidiosa</i> in Contact with <i>Paraburkholderia phytofirmans</i> Supernatant Reveals Changes in Nicotinamide, Amino Acids, Biotin, and Plant Hormones

    METABOLITES, v.14, n.2, article ID 82, 26p, 2024

    Microbial competition within plant tissues affects invading pathogens' fitness. Metabolomics is a great tool for studying their biochemical interactions by identifying accumulated metabolites. Xylella fastidiosa, a Gram-negative bacterium causing Pierce's disease (PD) in grapevines, secretes vari...

  9. Cardiac Remodeling in Subclinical Hypertrophic CardiomyopathyThe VANISH Randomized Clinical Trial

    JAMA CARDIOLOGY, v.8, n.11, 2023

    Importance Valsartan has shown promise in attenuating cardiac remodeling in patients with early-stage sarcomeric hypertrophic cardiomyopathy (HCM). Genetic testing can identify individuals at risk of HCM in a subclinical stage who could benefit from therapies that prevent disease progression.Obje...

  10. A BEAT-PCD consensus statement: a core outcome set for pulmonary disease interventions in primary ciliary dyskinesia

    ERJ OPEN RESEARCH, v.10, n.1, article ID 00115-2023, 11p, 2024

    Background Consistent use of reliable and clinically appropriate outcome measures is a priority for clinical trials, with clear definitions to allow comparability. We aimed to develop a core outcome set (COS) for pulmonary disease interventions in primary ciliary dyskinesia (PCD). Methods A multi...